KLK3 and prostate adenocarcinoma: In this case, the patient had a PSA value of 3.17 ng/mL in January 2022, about two months before the first complaint of eyelid edema and three months before the first imaging evaluation that revealed the brain tumor, later assumed to be a metastasis of prostate adenocarcinoma.